<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
72162-1614-2
</NDCCode>
<PackageDescription>
200 mL in 1 BOTTLE (72162-1614-2)
</PackageDescription>
<NDC11Code>
72162-1614-02
</NDC11Code>
<ProductNDC>
72162-1614
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Erythromycin Ethylsuccinate
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Erythromycin Ethylsuccinate
</NonProprietaryName>
<DosageFormName>
GRANULE, FOR SUSPENSION
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20160928
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA050207
</ApplicationNumber>
<LabelerName>
Bryant Ranch Prepack
</LabelerName>
<SubstanceName>
ERYTHROMYCIN ETHYLSUCCINATE
</SubstanceName>
<StrengthNumber>
200
</StrengthNumber>
<StrengthUnit>
mg/5mL
</StrengthUnit>
<Pharm_Classes>
Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2026-02-02
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20240206
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>